Michael Joseph Rybak

55PUBLICATIONS
112CO-AUTHORS
Medical bacteriologyMajor global burdens of diseaseMedical infection agents (incl. prions)Medical molecular engineering of nucleic acids and proteinsMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|May 15, 2026
Ceftazidime-avibactam for multidrug-resistant gram-negative infections: outcomes and timing of initiation across 22 U.S. medical centers.

|Mar 23, 2026
Real-world use of eravacycline for the treatment of mono- and polymicrobial infections involving Enterobacterales.

Sean R Van Helden, Ashlan J Kunz Coyne, Sara Alosaimy

|Dec 05, 2025
Impact of Pseudomonas aeruginosa biofilm exopolysaccharide composition on bacteriophage and bacteriophage-antibiotic combination activity.

Sean R Van Helden, Callan R Bleick, Dana J Holger

|Nov 18, 2025
Optimizing phage-antibiotic combinations: impact of administration order against daptomycin non-susceptible (DNS) MRSA clinical isolates.

Callan R Bleick, Sean R Van Helden, Andrew D Berti

|Aug 26, 2025
Eravacycline use in immunocompromised patients: multicenter evaluation of timely versus late initiation on clinical outcomes.

Ashlan J Kunz Coyne, Sara Alosaimy, Kristen Lucas

|Jun 21, 2025
Cefepime-taniborbactam: Ushering in the era of metallo-β-lactamase inhibition.

Sean R Van Helden, Mohammed Al Musawa, Callan R Bleick

Pageof 10

Frequent Collaborators

19 joint publications

Ashlan J Kunz Coyne

8 joint publications

Dana J Holger

7 joint publications

Taylor Morrisette

6 joint publications

Razieh Kebriaei